https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-rss/?orgId=115857&title=Liver+Center+News A selection of the latest research, academic, and other newsworthy developments at Liver Center en-us Copyright 2026 Yale School of Medicine Sun, 17 May 2026 23:28:42 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/to-fight-cancer-try-adding-exercise/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/to-fight-cancer-try-adding-exercise/ Growing evidence from Yale suggests that regular physical activity can help lower cancer risk and improve outcomes. Experts emphasize that while exercise isn’t a cure-all, even moderate activity may offer meaningful benefits. Thu, 14 May 2026 15:00:00 Z https://news.yale.edu/2026/04/08/serving-those-who-served-many-yale-physicians-veteran-care-has-become-mission https://news.yale.edu/2026/04/08/serving-those-who-served-many-yale-physicians-veteran-care-has-become-mission Generations of Yale physicians have treated patients and launched cutting-edge health care initiatives through Yale’s affiliation with the VA Connecticut Healthcare System. Wed, 08 Apr 2026 20:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/inaugural-connecticut-liver-health-day-aims-to-increase-awareness-of-liver-disease/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/inaugural-connecticut-liver-health-day-aims-to-increase-awareness-of-liver-disease/ Connecticut recently designated liver disease as a public health priority and established April 19 as an annual Connecticut Liver Health Day to promote awareness, prevention, and earlier detection of liver disease statewide. On April 19, 2026, Yale School of Medicine will co-host the Connecticut Liver Health Day Educational Luncheon with the Liver and Health Innovation Consortium. Mon, 30 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/fellow-focus-in-four-michail-kokkorakis-md-phd/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/fellow-focus-in-four-michail-kokkorakis-md-phd/ Meet postdoctoral fellow, Michail Kokkorakis, MD, PhD, whose work focuses on improving the detection and treatment of liver disease. Kokkorakis was recently selected as a Young Scientist for the 75th Lindau Nobel Laureate Meeting. Thu, 26 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/match-day-2026-yale-department-of-internal-medicine-announces-new-residents/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/match-day-2026-yale-department-of-internal-medicine-announces-new-residents/ The Yale Department of Internal Medicine announces its newest incoming class of residents for Match Day 2026. Fri, 20 Mar 2026 17:00:00 Z https://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-2026-national-scientific-and-health https://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-2026-national-scientific-and-health Yale School of Medicine's Gerald Shulman, MD, PhD, is a recipient of the 2026 Albert Renold Award from the American Diabetes Association. Tue, 10 Mar 2026 04:00:00 Z https://www.nytimes.com/2026/02/12/well/alcohol-body-health-effects.html https://www.nytimes.com/2026/02/12/well/alcohol-body-health-effects.html From the moment we take a sip, drinking starts to influence our biology. YSPH Professor Vasilis Vasiliou joins other experts in providing information about the impact of alcohol on personal health. Thu, 12 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/new-yale-inflammatory-bowel-disease-center/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/new-yale-inflammatory-bowel-disease-center/ Recent studies estimate that by 2035, one in 100 people in the United States will have inflammatory bowel disease (IBD), a chronic inflammation of the digestive system. In response to this growing demand for IBD care, Yale School of Medicine faculty established the new Yale Inflammatory Bowel Disease Center, which serves as a hub for research, clinical care, and medical education to improve the treatment of patients with IBD. Mon, 09 Feb 2026 14:30:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/chronic-hepatitis-c-linked-to-increased-risk-of-pancreatic-cancer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/chronic-hepatitis-c-linked-to-increased-risk-of-pancreatic-cancer/ A new study from Yale School of Medicine researchers found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic HCV infection have a 1.8-fold increased risk of pancreatic cancer compared to those who test negative for the virus. Mon, 17 Nov 2025 11:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/creating-spaces-of-care-nima-fattahi-md/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/creating-spaces-of-care-nima-fattahi-md/ Nima Fattahi, MD, an associate research scientist, works in the lab of Matthew McConnell, MD, exploring how alcohol affects liver function and immune pathways. His journey — from a small Kurdish city in Iran to the Yale Liver Center — reflects a lifelong commitment to bridging science, compassion, and community. Mon, 03 Nov 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/could-statins-help-treat-cirrhosis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/could-statins-help-treat-cirrhosis/ Tamar Taddei, MD, professor of medicine (digestive diseases), is investigating whether statins – a common, inexpensive medication – may be used to help treat cirrhosis and slow the progression to decompensated cirrhosis. In a Q&A, Taddei discusses current understanding of how statins function and her motivations and challenges in pursuing this line of research. Mon, 06 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/glp-1-receptor-agonists-protect-the-liver-during-alcohol-consumption/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/glp-1-receptor-agonists-protect-the-liver-during-alcohol-consumption/ New findings suggest GLP-1 receptor agonists like Ozempic reduce alcohol metabolism and its toxic metabolites. But they may also raise blood alcohol levels. Thu, 18 Sep 2025 19:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/collaborative-program-aims-to-improve-study-of-hiv-and-rheumatic-and-musculoskeletal-diseases-in-uganda/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/collaborative-program-aims-to-improve-study-of-hiv-and-rheumatic-and-musculoskeletal-diseases-in-uganda/ A new collaborative program, the Ugandan Registry of RMDs in HIV (GEMINI), aims to improve the study of HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda. Tue, 05 Aug 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/study-reveals-cholesterols-role-in-fibrotic-progression-of-metabolic-liver-disease/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/study-reveals-cholesterols-role-in-fibrotic-progression-of-metabolic-liver-disease/ In a new study, published in Proceedings of the National Academy of Sciences, Yale School of Medicine researchers showed that excess cholesterol stored in the liver can directly drive fibrosis in the context of metabolic disease. Tue, 29 Jul 2025 13:40:00 Z https://www.health.com/bmi-body-fat-percentage-more-reliaboe-study-11770445 https://www.health.com/bmi-body-fat-percentage-more-reliaboe-study-11770445 Recent research found that BMI is not a good predictor of mortality, adding to a growing body of evidence against the health metric. Here's what to measure instead. Tue, 15 Jul 2025 04:00:00 Z https://news.yale.edu/2025/07/03/cure-cystic-fibrosis-might-start-womb https://news.yale.edu/2025/07/03/cure-cystic-fibrosis-might-start-womb In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth.  Thu, 03 Jul 2025 17:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/apply-now-yale-liver-center-pilot-funding-2025/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/apply-now-yale-liver-center-pilot-funding-2025/ The NIH/NIDDK P30 Liver Center grant provides for the annual submission of pilot projects ($40,000 direct costs each) from both Liver Center and non-Liver Center investigators. Tue, 01 Jul 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/internal-medicine-promotions-appointments-may-2025/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/internal-medicine-promotions-appointments-may-2025/ Congratulations to the Yale Department of Internal Medicine faculty members who were recently promoted, appointed, or reappointed. Tue, 06 May 2025 04:00:00 Z https://www.medscape.com/viewarticle/targeted-crc-outreach-doubles-screening-rates-cuts-deaths-2025a1000a5r https://www.medscape.com/viewarticle/targeted-crc-outreach-doubles-screening-rates-cuts-deaths-2025a1000a5r A 20-year initiative that offered flexible CRC screening options is credited with dramatically increasing screening rates and decreasing incidence, while reducing racial disparities. Mon, 28 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/welcome-new-staff-faculty-postdocs-april-2025/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/welcome-new-staff-faculty-postdocs-april-2025/ The Department of Internal Medicine is pleased to welcome the following new staff, faculty, postdoctoral fellows, and postdoctoral associates who joined the team in March 2025. Tue, 08 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/advancing-aki-understanding-and-treatment/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/advancing-aki-understanding-and-treatment/ Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the development of new treatments for the condition, according to Yale School of Medicine researchers who published a review in The Journal of Clinical Investigation on March 17. Tue, 08 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/skin-injury-may-bring-on-food-allergies/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/skin-injury-may-bring-on-food-allergies/ A Yale lab links skin inflammation to the development of food allergies via a skin-gut connection, suggesting clues to a little-understood immune reaction. Fri, 04 Apr 2025 18:00:00 Z https://www.yalemedicine.org/news/wilson-disease-a-world-expert-eyes-gene-therapy https://www.yalemedicine.org/news/wilson-disease-a-world-expert-eyes-gene-therapy Yale Medicine’s world expert on Wilson disease discusses the latest knowledge about the rare genetic disorder that causes an overabundance of copper in the body. Fri, 04 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/joshua-warrick-md-to-succeed-peter-humphrey-md-phd-as-director-of-genitourinary-pathology/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/joshua-warrick-md-to-succeed-peter-humphrey-md-phd-as-director-of-genitourinary-pathology/ Joshua Warrick, MD, will join the Department of Pathology as a professor of pathology and senior research scientist on July 1, succeeding Peter Humphrey, MD, PhD, as director of genitourinary pathology. Tue, 01 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/targeting-hormones-could-reduce-risk-of-fatty-liver-disease/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/targeting-hormones-could-reduce-risk-of-fatty-liver-disease/ Fat buildup in the liver can lead to severe damage and cancer. A new Yale study finds a therapeutic target for those at higher risk of fatty liver disease. Tue, 25 Mar 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/match-day-2025-welcome-residents-to-yale-internal-medicine/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/match-day-2025-welcome-residents-to-yale-internal-medicine/ The Department of Internal Medicine announces its newest incoming class of residents for Match Day 2025. Fri, 21 Mar 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/connecticut-academy-of-science-and-engineering-elects-12-from-ysm/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/connecticut-academy-of-science-and-engineering-elects-12-from-ysm/ Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering. Tue, 18 Mar 2025 22:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/meet-yale-internal-medicine-basile-njei/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/meet-yale-internal-medicine-basile-njei/ Meet Basile Njei, MD, MPH, PhD, assistant professor of medicine (digestive diseases). Njei is combining genetics and artificial intelligence (AI) to improve clinical outcomes, detect liver disease, and identify genetic and clinical predictors of liver disease. Njei is currently the co-director of the International Medicine Program in the Section of Digestive Diseases, through which he collaborates with the U.S. embassy in Cameroon to improve medical education and integrate AI into health care in Africa. Thu, 06 Mar 2025 05:00:00 Z https://ventures.yale.edu/news/blavatnik-fund-innovation-yale-support-15-breakthrough-interventions-cardiometabolic https://ventures.yale.edu/news/blavatnik-fund-innovation-yale-support-15-breakthrough-interventions-cardiometabolic This year’s awardees are tackling some of the most urgent life science challenges with projects spanning novel therapeutics to AI-powered medical solutions. Fri, 28 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/yale-researchers-use-large-language-models-to-detect-gastrointestinal-bleeding/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/yale-researchers-use-large-language-models-to-detect-gastrointestinal-bleeding/ A team of Yale researchers demonstrated the effectiveness of a large language model (LLM)-based pipeline in identifying overt gastrointestinal bleeding in 1,108 patients seen between 2014 and 2023 in Yale New Haven Health. The study showed a high accuracy of the model in detecting melena, hematochezia, and hematemesis, identifying recurrent bleeding, and catching more than 98% of cases. The algorithm also increased the average per-patient reimbursement. Fri, 28 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/the-rules-of-immunity-what-decides-t-cell-fate/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/the-rules-of-immunity-what-decides-t-cell-fate/ Yale researchers have identified a lever that determines the fate of T cells, influencing whether they become killer cells or exhausted cells during an immune response. Thu, 27 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/voluntary-faculty-awards-honor-outstanding-educators/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/voluntary-faculty-awards-honor-outstanding-educators/ The Yale Department of Internal Medicine recently presented its second Voluntary Faculty Awards, which honored voluntary faculty who are involved in teaching medical students, physician associate students, residents, and fellows across Yale School of Medicine (YSM) and Yale New Haven Health (YNHHS) affiliated hospitals. Tue, 18 Feb 2025 13:30:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/what-makes-successful-heart-failure-drug-work/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/what-makes-successful-heart-failure-drug-work/ Researchers across Yale School of Medicine published a new study in The Journal of Clinical Investigation that sheds light on how SGLT2 inhibitors work to protect the heart. Tue, 18 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/can-type-2-diabetes-be-reversed/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/can-type-2-diabetes-be-reversed/ Research shows that most cases of type 2 diabetes can be prevented through lifestyle interventions. But if you already have the condition, can it be reversed? Yale School of Medicine experts weigh in. Wed, 12 Feb 2025 16:40:00 Z https://news.yale.edu/2025/02/05/study-reveals-how-gut-bacteria-might-trigger-autoimmune-diseases-lupus https://news.yale.edu/2025/02/05/study-reveals-how-gut-bacteria-might-trigger-autoimmune-diseases-lupus Gut bacteria are increasingly implicated in non-gut-related autoimmune diseases. Yale researchers have begun to understand how they’re connected. Fri, 07 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/responding-to-rise-of-metabolic-liver-disease-in-connecticut/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/responding-to-rise-of-metabolic-liver-disease-in-connecticut/ Metabolic liver diseases are on the rise in Connecticut. Yale faculty joined a new state working group to respond to the increase in the prevalence of these diseases. The working group recently issued recommendations to increase awareness and education and improve public health infrastructure. Mon, 27 Jan 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/the-link-between-alcohol-and-cancer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/the-link-between-alcohol-and-cancer/ U.S. Surgeon General Vivek Murthy has issued an advisory calling for updated warnings on alcoholic beverages, cautioning that the consumption of alcohol heightens the risk of several types of cancer. YSPH epidemiologist Vasilis Vasiliou elaborates on the concerns. Tue, 21 Jan 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/digestive-health-cme-series-2025/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/digestive-health-cme-series-2025/ The Trust Your Gut continuing medical education (CME) series is returning for 2025 to provide physicians and advanced practice providers with world-class, evidence-based digestive disease education. Each webinar will be delivered by experts across the Yale School of Medicine. Mon, 06 Jan 2025 05:00:00 Z https://www.courant.com/2025/01/04/ct-cancer-expert-on-u-s-surgeon-general-on-alcohol-and-cancer-risk-cutting-back-makes-sense/ https://www.courant.com/2025/01/04/ct-cancer-expert-on-u-s-surgeon-general-on-alcohol-and-cancer-risk-cutting-back-makes-sense/ Oncologists with Yale Cancer Center are praising a report released by the Office of the Surgeon General that seeks to add a warning label on alcoholic beverages showing the direct link between drinking and fatal cancers. YSPH Professor Vasilis Vasiliou comments. Sat, 04 Jan 2025 05:00:00 Z https://www.wtnh.com/news/health/yale-cancer-center-doctor-endorses-cancer-warnings-on-alcohol/ https://www.wtnh.com/news/health/yale-cancer-center-doctor-endorses-cancer-warnings-on-alcohol/ YSPH Professor Vasilis Vasiliou discusses the U.S. Surgeon General's call for warning labels on alcoholic beverages due to scientific information linking alcohol consumption to cancer. Fri, 03 Jan 2025 05:00:00 Z https://ventures.yale.edu/news/yale-life-science-pitchfest-2024-showcases-groundbreaking-research-and-innovation https://ventures.yale.edu/news/yale-life-science-pitchfest-2024-showcases-groundbreaking-research-and-innovation From novel therapeutic treatments for obesity and endometriosis to a simulated psychedelic immersive experience to treat depression and a unisex non-hormonal contraceptive, the 2024 Yale Life Science PitchFest showcased Yale's most promising life science innovations from 34 Yale faculty-led teams. Thu, 12 Dec 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/2025-ycci-funding-opportunities-open-for-applications/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/2025-ycci-funding-opportunities-open-for-applications/ The Yale Center for Clinical Investigation (YCCI) has announced a request for applications for several awards: - YCCI Scholar Awards and OPSSD Yale Physician-Scientist Development Awards - YCCI Multidisciplinary Post-Doctoral Training Program - YCCI Multidisciplinary Pre-Doctoral Training Program Mon, 02 Dec 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/liver-cancer-screening-new-tool-improved-detection/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/liver-cancer-screening-new-tool-improved-detection/ Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. Screening efforts for this cancer focus on individuals diagnosed with viral hepatitis or those known to have irreversible liver scarring, or cirrhosis. Due in part to increasing rates of obesity, another major risk factor is emerging, metabolic dysfunction-associated steatotic liver disease (MASLD), but factors associated with MASLD are not included in current screening practices. In response, researchers at Yale have developed and validated a new risk score for hepatocellular carcinoma that considers these factors. Their work, “Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis” was published on November 6, 2024, in JAMA Network Open. Fri, 08 Nov 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/how-diet-interacts-with-the-gut/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/how-diet-interacts-with-the-gut/ The 14th Iva Dostanic lectureship took place on Thursday, June 20, 2024 with Lisa Korn, MD, PhD, instructor of medicine (rheumatology, allergy and immunology), presenting her research findings on diet-immune interactions. Wed, 02 Oct 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/neutrophils-in-the-immune-system-do-more-than-fight-bacteria-and-viruses/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/neutrophils-in-the-immune-system-do-more-than-fight-bacteria-and-viruses/ Our body’s most common immune cells have a reputation for destruction and inflammation. Now, researchers are beginning to realize there’s another side to the neutrophil. Tue, 24 Sep 2024 04:00:00 Z https://click.message.yale.edu/?qs=c692522f1b39b7729bb710355a5e6b015a4ea613f99af5d3f88f6f4f2feeda161d0076dcb61753a70e6875770a97abda93a0db5fa5312fbe https://click.message.yale.edu/?qs=c692522f1b39b7729bb710355a5e6b015a4ea613f99af5d3f88f6f4f2feeda161d0076dcb61753a70e6875770a97abda93a0db5fa5312fbe Wajahat Mehal. MD, professor of medicine (digestive diseases) at Yale School of Medicine, discusses the limitations of using BMI to determine a healthy weight. Thu, 19 Sep 2024 04:00:00 Z https://www.msn.com/en-us/health/other/weight-loss-drugs-could-help-fight-fatty-liver-disease/ar-AA1qMOQg?ocid=Peregrine https://www.msn.com/en-us/health/other/weight-loss-drugs-could-help-fight-fatty-liver-disease/ar-AA1qMOQg?ocid=Peregrine A new study by researchers at Yale School of Medicine (YSM), published Aug. 27 in the journal Cell Metabolism, finds that people with MASLD burn fat in their livers at the same rate as people without the disease. The study, whose senior author is Gerald Shulman, MD, Ph.D., George R. Cowgill Professor of Medicine (Endocrinology) and professor of cellular and molecular physiology at YSM, appears to settle this question, which has been in dispute in the field. Wed, 18 Sep 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/liver-cancer-screening-post-hep-c-cure-improves-survival/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/liver-cancer-screening-post-hep-c-cure-improves-survival/ Hepatocellular carcinoma is the most common form of liver cancer in adults. Hepatitis C infection is a known cause of hepatocellular carcinoma because the virus causes chronic inflammation and scarring of the liver, known as cirrhosis. Newer anti-viral drugs offer highly effective cures for hepatitis C, leading to stabilization of hepatitis C-related liver disease and decreased rates of hepatocellular carcinoma. Although new infections can occur at any age, the “baby boomer” generation born between 1945-1965 represents the largest population affected by hepatitis C in the United States. Yale's new research looked at whether ongoing liver cancer screening for individuals who achieved hepatitis C cure improves their overall survival rates. Tue, 10 Sep 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/first-ehr-machine-learning-model-for-gi-bleeding/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/first-ehr-machine-learning-model-for-gi-bleeding/ Yale researchers are developing a machine-learning risk model that uses electronic health record (EHR) data to provide an initial patient assessment based on symptoms rather than where the bleeding is thought to be. In a new paper, they evaluate the machine learning risk model against clinical risk scores to determine the most accurate approach. Mon, 09 Sep 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/gut-microbiome-imbalance-promotes-liver-disease-in-cystic-fibrosis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/livercenter/news-article/gut-microbiome-imbalance-promotes-liver-disease-in-cystic-fibrosis/ About 30% of patients with cystic fibrosis report liver abnormalities and 10% of these patients go on to experience severe liver disease. Traditionally, cystic fibrosis-related liver disease was thought to be caused primarily by defective bile secretion due to the dysfunctional CFTR protein, which limited treatment options. Yale’s recent study led by Romina Fiorotto, PhD, and Mario Strazzabosco, MD, PhD, has identified a connection between the gut microbiome and the development of liver disease in cystic fibrosis patients. Tue, 27 Aug 2024 04:00:00 Z